Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

pembrolizumab 69 Nivolumab 57 Ipilimumab 36 Specimen Handling 32 Magnetic Resonance Spectroscopy 25 Cyclophosphamide 23 Biopsy 18 cemiplimab 14 fludarabine 13 relatlimab 11 binimetinib 11 Opdualag 11 CTLA-4 Antigen 11 trametinib 10 fludarabine phosphate 10 Radiosurgery 10 avelumab 9 Radiotherapy 9 lifileucel 8 dabrafenib 8 Blood Specimen Collection 8 atezolizumab 7 aldesleukin 7 Paclitaxel 7 encorafenib 6 X-Rays 6 Standard of Care 6 Interleukin-2 6 Immunoglobulin G 6 HhAntag691 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

hypericin × Dermatologic × 90 days × Clear all

NCT06470451 2026-04-03

FLASH2

Soligenix

Phase 3 Recruiting

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡